|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||
| Current assets | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Restricted cash | ||||||||||||||||||||
| Accounts receivable, net | ||||||||||||||||||||
| Inventories, net | ||||||||||||||||||||
| Prepaid expenses and other | ||||||||||||||||||||
| Current assets held-for-sale | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Property, plant and equipment, net | ||||||||||||||||||||
| Deferred income taxes | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Other intangible assets, net | ||||||||||||||||||||
| GM postretirement cost sharing asset | ||||||||||||||||||||
| Operating lease right-of-use assets | ||||||||||||||||||||
| Investments in equity-method affiliates | ||||||||||||||||||||
| Other assets and deferred charges | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| Liabilities and Stockholders’ Equity | ||||||||||||||||||||
| Current liabilities | ||||||||||||||||||||
| Current portion of long-term debt | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Accrued compensation and benefits | ||||||||||||||||||||
| Deferred revenue | ||||||||||||||||||||
| Current portion of operating lease liabilities | ||||||||||||||||||||
| Accrued expenses and other | ||||||||||||||||||||
| Current liabilities held-for-sale | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Long-term debt, net | ||||||||||||||||||||
| Deferred revenue | ||||||||||||||||||||
| Deferred income taxes | ||||||||||||||||||||
| Long-term portion of operating lease liabilities | ||||||||||||||||||||
| Postretirement benefits and other long-term liabilities | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Stockholders' equity | ||||||||||||||||||||
| Preferred stock, par value $0.01 per share; 10.0 million shares authorized; no shares outstanding in 2025 or 2024 | ||||||||||||||||||||
| Series common stock, par value $0.01 per share; 40.0 million shares authorized; no shares outstanding in 2024 or 2023 | ||||||||||||||||||||
| Series common stock, par value $0.01 per share; 40.0 million shares authorized; no shares outstanding in 2025 or 2024 | ||||||||||||||||||||
| Common stock, par value $0.01 per share; 375.0 million shares authorized as of June 30, 2026 and 150.0 million shares authorized as of December 31, 2025; 250.0 million shares issued as of June 30, 2026 and 130.0 million shares issued as of December 31, 2025 | ||||||||||||||||||||
| Paid-in capital | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Treasury stock at cost, 12.5 million shares as of June 30, 2026 and 11.3 million shares as of December 31, 2025 | ||||||||||||||||||||
| Accumulated other comprehensive income (loss) | ||||||||||||||||||||
| Defined benefit plans, net of tax | ||||||||||||||||||||
| Foreign currency translation adjustments | ||||||||||||||||||||
| Unrecognized gain on hedges, net of tax | ||||||||||||||||||||
| Total Dauch stockholders' equity | ||||||||||||||||||||
| Noncontrolling interests in subsidiaries | ||||||||||||||||||||
| Total stockholders' equity | ||||||||||||||||||||
| Total liabilities and stockholders' equity |
Loading...
